SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble is trending amid news of acquiring AI infrastructure company Northern Data and securing a significant advertising commitment from Tether. The community is buzzing about the potential impact of Tether's increased stake and advertising commitment, as well as the possibility of a short squeeze. Discussions involve the potential market capitalization post-merger and Rumble's position in the cloud services sector.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is trending amid discussions about the government shutdown, potential $2000 dividend payments, and the recent local elections. Community members are debating the impact of Trump's policies, particularly tariffs and healthcare, with some expressing concern over potential market manipulation. There's also active discussion around the company's financial performance.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group ($UNH) is trending due to concerns around government shutdowns impacting ACA subsidies and potential shifts in healthcare funding models, sparking debate about the company's future. Community discussions revolve around potential impacts to UNH's revenue and profitability, with some speculating about Warren Buffett's position and potential DOJ case outcomes. Traders are closely monitoring support levels and potential catalysts, like upcoming 13F filings and healthcare conferences.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR Protocol is trending due to its AI-native design and recent user growth, surpassing Solana and Ethereum in active users. Community members are discussing its scalability, interoperability, and strong tokenomics, while some speculate about potential price targets and future developments in the AI sector.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BBAI is trending as investors brace for upcoming earnings, with opinions split on whether the company can deliver. The reopening of the government is also a key focus, with many anticipating new contract announcements. The community is actively debating potential price movements and long-term prospects amidst broader market volatility affecting AI stocks.

Concordium is the Layer-1 blockchain built for a new era of digital trust. With mandatory, privacy-preserving identity verification built into its consensus layer, utilizing zero-knowledge proof technology. Concordium also enables Protocol-level tokens that eliminate smart contract risks by being issued directly at the consensus layer, with built-in features that provide the infrastructure for compliance-ready use cases. At its core is Smart Money - programmable, identity-embedded, and compliance-ready value that powers trusted interactions across Web3. Smart Money enables frictionless exchange, automation, and verifiable trust by design. Unlike conventional blockchains, Concordium integrates trust, accountability, and privacy into its architecture from the ground up  bridging traditional systems and Web3 to build a transparent, sustainable digital future. The name Concordium comes from the Latin concordia—meaning harmony and agreement—a reflection of its mission to build infrastructure that embeds trust, privacy, and compliance into every interaction.

Concordium

Concordium ($CCD) is trending as the community highlights its focus on compliance-ready infrastructure, privacy-preserving technology, and real-world utility within the PayFi ecosystem. Recent partnerships, including integrations with Ledger and bitcoin.com/, are driving increased attention and bullish sentiment, positioning Concordium as a standout Layer-1 blockchain for enterprise adoption and regulated DeFi.

FedEx Corp. is a holding company, which engages in the provision of transportation, e-commerce, business services, and business solutions. It operates through the following segments: FedEx Express, FedEx Freight, Corporate, Other, and Eliminations. The FedEx Express segment offers transportation and delivery services. The FedEx Freight segment refers to freight transportation services to business and residences. The FedEx Services segment includes sales, marketing, information technology, communications, customer service, technical support, billing and collection services, and certain back-office functions that support the company's operating segments. The Corporate, Other, and Eliminations segment is involved in the corporate headquarters costs for executive officers and certain legal and finance functions, as well as certain other costs and credits not attributed to the firm's core business. The company was founded by Frederick Wallace Smith on June 18, 1971, and is headquartered in Memphis, TN.

Fedex Corp

Recent FAA flight reductions and a UPS plane crash are sparking discussions around potential disruptions to cargo deliveries and the impact on logistics companies like FedEx. The community is also weighing in on FedEx's cost-cutting initiatives and the potential benefits from increased e-commerce and peak season demand. Furthermore, some analysts are adjusting their ratings and price targets for FDX.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

CRISPR Therapeutics is trending following positive Phase 1 clinical data for its CTX310 gene-editing therapy, which showed significant reductions in cholesterol and triglycerides. The community is buzzing about the potential of this 'one and done' treatment to disrupt the pharmaceutical industry and potentially lead to a buyout, while some are comparing the news to previous announcements that did not move the stock as much.

Semler Scientific, Inc. engages in the provision of technology and software solutions to improve the clinical effectiveness of healthcare providers. Its multi-test service platform, WellChec, comprehensively evaluates its customers’ patients for chronic disease, including heart attacks and strokes, using its QuantaFlo product as well as other tests. The company was founded by Herbert J. Semler, Guinasso Cindy and Shirley L. Semler on August 9, 2007 and is headquartered in Campbell, CA.

Semler Scientific Inc

Semler Scientific is trending due to its pending merger with Strive, with the community actively discussing the potential of the combined entity holding a significant amount of Bitcoin. Bullish sentiment is fueled by the perceived undervaluation of SMLR compared to its Bitcoin holdings and the potential for ASST to rise, impacting SMLR's value. However, concerns about the merger terms, potential lawsuits, and dilution are also being debated.

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

$DOG is trending as a meme coin built on the Bitcoin network, with the community emphasizing its fair launch and strong grassroots support. Discussions highlight its potential to onboard new users to Bitcoin and challenge existing meme coins. The community also anticipates potential listings on major exchanges.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Morgan Stanley, Evercore ISI, and Barclays raised price targets to between $28–$32, citing Omada’s revenue growth and its first positive adjusted EBITDA.</li><li>The company plans to integrate GLP-1 prescribing and medication management into its weight-health program, expanding its digital-care platform.</li><li>Retail traders highlighted the company’s strong balance sheet, high gross margins, and operating leverage as signs of growth potential.</li></ul><p>Retail chatter on Omada Health surged over the weekend after several brokerages raised price targets following stronger-than-expected third-quarter (Q3) results and the company’s new GLP-1 prescribing initiative for its weight-health program.</p><h2 class="st-heading-2"><strong>Analyst Upgrades</strong></h2><p>Morgan Stanley raised its price target on Omada Health to $32 from $30 and kept an ‘Overweight’ rating, citing 49% year-over-year revenue growth, an 11% beat versus consensus, and the company’s first quarter of positive adjusted EBITDA. The firm said momentum continues and highlighted the addition of GLP-1 prescribing to Omada’s offering as a key development.</p><p>Evercore ISI increased its price target to $28 from $27 and maintained an ‘Outperform’ rating, noting that Q3 revenue and EBITDA beat expectations and full-year 2025 guidance was raised.</p><p>Barclays lifted its price target to $29 from $28 and reiterated an ‘Overweight’ rating, describing Omada’s results as “another beat and raise quarter.”</p><h2 class="st-heading-2"><strong>Q3 Review</strong></h2><p>Omada reported revenue of $68 million, ahead of consensus estimates of $61.2 million. Total members rose 53% to 831,000, while the company’s net loss narrowed to $3 million from $9 million a year earlier. Omada achieved its first positive adjusted EBITDA of $2 million, compared with a $5 million loss in the prior-year period.</p><p>Gross margin improved to 66%, and cash and cash equivalents totaled $199 million at quarter-end.</p><p>CEO Sean Duffy said the results demonstrate “the strength of Omada’s multi-product platform” as the company deepens its innovation in GLP-1 care options and AI tools aimed at delivering “sustainable outcomes” and “cost savings” for customers.</p><h2 class="st-heading-2"><strong>GLP-1 Expansion And Product Updates</strong></h2><p>The company announced plans to integrate prescribing and medication management for anti-obesity medications, including GLP-1s, into its weight-health program.</p><p>Omada also launched Meal Map, an AI-driven nutrition platform that prioritizes nutrient quality over calorie tracking, and published results from its 30th peer-reviewed research study, which showed savings generated from its Joint &amp; Muscle Health program. Additional results showed that members largely sustained their weight a year after stopping GLP-1 treatment.</p><h2 class="st-heading-2"><strong>Financial Outlook</strong></h2><p>Omada raised its FY25 revenue guidance to $251.5 million-$254.5 million, up from a prior range of $235 million–$241 million, and now expects adjusted EBITDA between breakeven and a $2 million loss, compared with earlier guidance for a $9 million–$5 million loss.</p><h2 class="st-heading-2"><strong>Stocktwits Traders Say Omada’s GLP-1 Plan Shows Real Execution</strong></h2><p>On Stocktwits, retail sentiment for Omada was ‘extremely bullish’ amid ‘extremely high’ message volume.</p><figure class="image"><img style="aspect-ratio:963/138;" src="https://news.stocktwits-cdn.com/omda_ss_jpg_d120b63835.webp" alt="omda ss.jpg" width="963" height="138"><figcaption>OMDA sentiment and message volume as of November 9 | Source: Stocktwits</figcaption></figure><p>One user said some companies “just mention GLP-1 to garner headlines” without clear execution plans, but noted that Omada Health already has case studies, proof-of-concept, and “the balance sheet to boost this up.” They added that the business model is proven and now depends on strong marketing to capture the opportunity.</p><p><stembedurl>https://stocktwits.com/Jasooon/message/635551904</stembedurl></p><p>Another user said the company’s financials “prove it,” pointing to high gross margins, positive adjusted EBITDA, and improved cash flow as signs of operating leverage and a “stellar management team.”</p><p><stembedurl>https://stocktwits.com/Jasooon/message/635551456</stembedurl></p><p><a href="https://stocktwits.com/symbol/OMDA">Omada Health’s stock</a> has declined 12% so far in 2025.</p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

In this photo illustration, the Omada Health logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Omada Health Stock Jumps Into Retail Focus As Wall Street Lifts Price Targets After ‘Beat And Raise’ Quarter, GLP-1 Push

Morgan Stanley, Evercore ISI, and Barclays raised price targets to between $28–$32, citing Omada’s revenue growth and its first positive adjusted EBITDA.

Equity

Teacher Retirement System of Texas Acquires New Stake in Omada Health, Inc. $OMDA

Teacher Retirement System of Texas bought a new position in Omada Health, Inc. (NASDAQ:OMDA - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities...

Omada Health (NASDAQ:OMDA) Price Target Raised to $29.00

Barclays increased their target price on shares of Omada Health from $28.00 to $29.00 and gave the stock an "overweight" rating in a research report on Friday...

Omada Health (NASDAQ:OMDA) Trading Down 11.1% - Time to Sell?

Omada Health (NASDAQ:OMDA) Trading Down 11.1% - Here's Why...

Omada Health (NASDAQ:OMDA) Price Target Raised to $28.00

Evercore ISI increased their target price on Omada Health from $27.00 to $28.00 and gave the stock an "outperform" rating in a research report on Friday...

Needham & Company LLC Issues Positive Forecast for Omada Health (NASDAQ:OMDA) Stock Price

Needham & Company LLC increased their price objective on shares of Omada Health from $26.00 to $28.00 and gave the stock a "buy" rating in a research note on Friday...

Omada Health (NASDAQ:OMDA) Releases Quarterly Earnings Results, Beats Estimates By $0.21 EPS

Omada Health (NASDAQ:OMDA - Get Free Report) announced its quarterly earnings results on Thursday. The company reported ($0.03) EPS for the quarter, beating the consensus estimate of ($0.24) by $0.21...

Compared to Estimates, Omada Health, Inc. (OMDA) Q3 Earnings: A Look at Key Metrics

The headline numbers for Omada Health, Inc. (OMDA) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Startup Omada Health to start prescribing GLP-1s, other obesity medications as membership grows

The announcement expands the offerings under the company's weight management program as its membership grows to more than 100,000...

15 names that Morgan Stanley’s analysts expect to move meaningfully on earnings

Investing.com -- Morgan Stanley expects a “normal” earnings beat rate for the second quarter, with S&P 500 EPS growth forecast at 5% year-over-year and sales up 4%.

Omada Health, Inc. engages in the provision of digital health services. It offers online diabetes and obesity prevention programs, health coaching, and integration of web, mobile, and smart devices. The company was founded by Andrew DiMichele, Adrian James, and Sean Duffy on April 25, 2011 and is headquartered in South San Francisco, CA.

Omada Health Inc.

$ASTS

$RKLB

$BBAI

$NBIS

Which earnings release are you most excited for the week of Nov. 10? 
 
Drop a comment for others.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.03	--	--	N/A
Q3 '25	-$0.08	-$0.06	24.03%	BEAT
Q2 '25	-$0.12	-$0.24	-102.82%	MISSED

OMDA
Omada Health, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q3 '25

Historical Earnings

Latest OMDA News

OMDAOmada Health, Inc.